SkinMedica® Deepens Commitment to Regenerative Science with Continued Investment in Research and Development

SkinMedica® announced the launch of a Regenerative Science Advisory Board to help shape future innovation, alongside expanded state-of-the-art R&D capacity to support next-generation science-led products. The company also debuted flagship retail experiences aimed at supporting practices and patients. Overall, this appears to be a positive product/strategy update with limited near-term financial impact given no quantified guidance or results were provided.

Analysis

SkinMedica® announced the launch of a Regenerative Science Advisory Board to help shape future innovation, alongside expanded state-of-the-art R&D capacity to support next-generation science-led products. The company also debuted flagship retail experiences aimed at supporting practices and patients. Overall, this appears to be a positive product/strategy update with limited near-term financial impact given no quantified guidance or results were provided.